This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Tracy Dowling
Chief Business Officer and General Counsel at AskBio
Speaker

Profile

As AskBio’s Chief Business Officer and General Counsel, Tracy Dowling brings over 15 years of life sciences and biotech experience to AskBio. She is responsible for the company’s global business development strategy and execution, as well as Alliance Management, Legal, Compliance and Corporate Communications. Prior to joining AskBio, Tracy served as Associate General Counsel at Spark Therapeutics providing legal oversight for essential business functions, including business development, licensing transactions, corporate governance, securities compliance, and real estate and construction. Notably, she played an integral role in Roche’s $4.6 billion acquisition of Spark. Earlier in her career, Tracy was an attorney at Morgan, Lewis & Bockius LLP, specializing in corporate transactional and securities matters. She also served in similar roles at Ballard Spahr LLP and the Monitor Group in London. She holds an undergraduate degree from Princeton University and a JD from Boston University School of Law.

Agenda Sessions

  • Engineering Value – Crafting BD Strategies that Win in Rare Disease

    9:45am